NUWIQ Trademark

Trademark Overview

On Friday, August 9, 2013, a trademark application was filed for NUWIQ with the United States Patent and Trademark Office. The USPTO has given the NUWIQ trademark a serial number of 79138098. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, September 25, 2024. This trademark is owned by Octapharma AG. The NUWIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII
nuwiq

General Information

Serial Number79138098
Word MarkNUWIQ
Filing DateFriday, August 9, 2013
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, September 25, 2024
Registration Number4496748
Registration DateTuesday, March 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2013

Trademark Statements

Goods and ServicesPharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 12, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLachen CH8853
CH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLachen CH8853
CH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLachen CH8853
CH

Trademark Events

Event DateEvent Description
Monday, November 25, 2013ASSIGNED TO EXAMINER
Monday, November 11, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 12, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 16, 2013APPLICATION FILING RECEIPT MAILED
Monday, November 25, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2013NOTICE OF PUBLICATION
Wednesday, December 11, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, December 31, 2013PUBLISHED FOR OPPOSITION
Thursday, April 17, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 31, 2013NOTIFICATION PROCESSED BY IB
Friday, January 3, 2014NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 18, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, June 5, 2014FINAL DISPOSITION PROCESSED
Thursday, June 5, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 4, 2014NOTIFICATION PROCESSED BY IB
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 18, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 14, 2020TEAS SECTION 71 & 15 RECEIVED
Wednesday, April 1, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 10, 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Saturday, April 11, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Saturday, March 18, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, August 10, 2023INTERNATIONAL REGISTRATION RENEWED
Friday, January 12, 2024TEAS SECTION 71 RECEIVED
Monday, September 23, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 25, 2024REGISTERED-SEC.71 ACCEPTED
Wednesday, September 25, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

nuwiq factors particularly viii recombinant coagulation products namely blood pharmaceutical